Cargando…
Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception(†)
Cyclin-dependent kinase 2 (CDK2) is a member of the larger cell cycle regulating CDK family of kinases, activated by binding partner cyclins as its name suggests. Despite its canonical role in mitosis, CDK2 knockout mice are viable but sterile, suggesting compensatory mechanisms for loss of CDK2 in...
Autores principales: | Faber, Erik B, Wang, Nan, Georg, Gunda I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523694/ https://www.ncbi.nlm.nih.gov/pubmed/32543655 http://dx.doi.org/10.1093/biolre/ioaa107 |
Ejemplares similares
-
Retinoic acid receptor antagonists for male contraception: current status(†)
por: Noman, Md Abdullah Al, et al.
Publicado: (2020) -
Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis
por: Hanna, Carol B, et al.
Publicado: (2020) -
The Na(+) and K(+) transport system of sperm (ATP1A4) is essential for male fertility and an attractive target for male contraception
por: Syeda, Shameem Sultana, et al.
Publicado: (2020) -
Testis-specific serine kinase protein family in male fertility and as targets for non-hormonal male contraception
por: Salicioni, Ana M, et al.
Publicado: (2020) -
The role of team science in the future of male contraception
por: Vahdat, Heather L, et al.
Publicado: (2020)